Role of circulating CD14++CD16+ monocytes and VEGF-B186 in formation of collateral circulation in patients with

He Zhang1, Shi-Lei Wang2, Tao Sun3

  • 1Department of Cardiology, The Third Hospital of Shijiazhuang City, Shijiazhuang, 050000, China.

Heliyon
|July 17, 2023
PubMed

Insights

Higher levels of intermediate monocytes and VEGF-B186 in acute myocardial infarction (AMI) patients correlate with better collateral circulation. This suggests these factors are key for healing AMI and improving blood flow.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Regenerative Medicine

Background:

  • Insufficient collateral circulation is a significant issue in acute myocardial infarction (AMI) patients.
  • CD14++CD16+ monocytes (intermediate monocytes, IM) and vascular endothelial growth factors (VEGFs) are linked to collateral circulation development.

Purpose of the Study:

  • To investigate the association between circulating intermediate monocytes, VEGF levels, and collateral formation in AMI patients.
  • To explore the relationship between these factors and left ventricular remodeling post-AMI.

Main Methods:

  • Enrolled 49 patients with AMI undergoing emergency percutaneous transluminal coronary intervention (PCI) and 27 patients undergoing delayed PCI.
  • Measured circulating IM percentage and VEGF levels on day 8 post-AMI; assessed left ventricular ejection fraction (LVEF) at 3 months.

Main Results:

  • Patients with well-developed collateral circulation had higher IM and VEGF levels on day 8.
  • VEGF-B186 levels positively correlated with IM in circulation.
  • Higher IM and VEGF-B186 levels were associated with milder left ventricular remodeling.

Conclusions:

  • Hyperacute collateral formation in AMI is linked to increased circulating CD14++CD16+ monocytes and VEGF-B186.
  • Targeting IM and VEGF-B may be crucial for enhancing collateral circulation and promoting healing in AMI.
Abstract